Armoda, Joel .
HRN: 20-88-89 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/03/2025
CIPROFLOXACIN 500MG (TAB)
10/03/2025
10/09/2025
ORAL
500 Mg
BID
AGE
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes